Reyon Pharmaceutical Co Ltd (102460) - Total Liabilities

Latest as of September 2025: ₩239.99 Billion KRW ≈ $162.63 Million USD

Based on the latest financial reports, Reyon Pharmaceutical Co Ltd (102460) has total liabilities worth ₩239.99 Billion KRW (≈ $162.63 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Reyon Pharmaceutical Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.

Reyon Pharmaceutical Co Ltd - Total Liabilities Trend (2008–2024)

This chart illustrates how Reyon Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 102460 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Reyon Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Reyon Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Hsinli Chemical Industrial TWO:4303	Taiwan	NT$835.07 Million
Sungshin Cemen KO:004980	Korea	₩714.35 Billion
Daedong Ind KO:000490	Korea	₩1.63 Trillion
Canaan Inc NASDAQ:CAN	USA	$150.13 Million
Stalexport Autostrady SA WAR:STX	Poland	zł392.33 Million
Land General Bhd KLSE:3174	Malaysia	RM644.36 Million
Pioneer Floating Rate Trust NYSE:PHD	USA	$66.83 Million
OM Holdings Ltd KLSE:5298	Malaysia	RM413.13 Million

Liability Composition Analysis (2008–2024)

This chart breaks down Reyon Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Reyon Pharmaceutical Co Ltd market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.60	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.03	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.51	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Reyon Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Reyon Pharmaceutical Co Ltd (2008–2024)

The table below shows the annual total liabilities of Reyon Pharmaceutical Co Ltd from 2008 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩250.05 Billion ≈ $169.46 Million	-0.44%
2023-12-31	₩251.15 Billion ≈ $170.20 Million	+6.00%
2022-12-31	₩236.93 Billion ≈ $160.56 Million	+1.80%
2021-12-31	₩232.74 Billion ≈ $157.73 Million	+165.93%
2020-12-31	₩87.52 Billion ≈ $59.31 Million	+67.69%
2019-12-31	₩52.19 Billion ≈ $35.37 Million	-32.90%
2018-12-31	₩77.77 Billion ≈ $52.71 Million	+9.27%
2017-12-31	₩71.18 Billion ≈ $48.24 Million	+133.83%
2016-12-31	₩30.44 Billion ≈ $20.63 Million	-0.42%
2012-12-31	₩30.57 Billion ≈ $20.72 Million	+6.39%
2011-12-31	₩28.73 Billion ≈ $19.47 Million	+29.70%
2009-12-31	₩22.15 Billion ≈ $15.01 Million	-2.14%
2008-12-31	₩22.64 Billion ≈ $15.34 Million	--

About Reyon Pharmaceutical Co Ltd

KO:102460 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$123.18 Million

₩181.76 Billion KRW

Market Cap Rank

#18333 Global

#782 in Korea

Share Price

₩9910.00

Change (1 day)

+0.41%

52-Week Range

₩9770.00 - ₩12570.00

All Time High

₩70413.22